Search

Ingelvac CircoFLEX

For the active immunisation of pigs over the age of two weeks against porcine circovirus type 2 to reduce mortality, clinical signs – including weight loss – and lesions in lymphoid tissues associated with porcine circovirus diseases (PCVD).

Boehringer Ingelheim reaches more patients than ever in 2022 as innovative medicines drive growth

Boehringer Ingelheim today reported a strong performance in 2022

1990-2022: Value through Innovation

The Boehringer Ingelheim history from 1990 to 2022, with milestones

COVID-19 Q&A for Patients

Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19

Boehringer Ingelheim inaugurates new milestone on its long-term commitment to the Kingdom

2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic

Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline

In 2023, Boehringer Ingelheim in India, Middle East, Turkey and Africa (IMETA) region achieved net sales of EUR 779 million, reflecting a 13% increase compared to the previous year.

Advancing regenerative medicine

Strategic partnerships play a key role in helping the company accelerate the next generation of breakthroughs.

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

“Rapid progress towards clinical candidates”

Boehringer Ingelheim forms a joint venture to create the next generation of antimicrobials.

Clinical Trial Demonstrates Positive Top-Line Results Reducing Risk Cardiovascular

Clinical Trial Demonstrates Positive Top-Line Results in Reducing the Risk for Cardiovascular Death or Hospitalisation due to Heart Failure

Boehringer Ingelheim Opens New Scientific Office in Kenya as Part of its Commitment to Improve Human and Animal Health in Africa

Boehringer Ingelheim has officially opened its new scientific office in Nairobi, Kenya.

Innovation Prize Winners

Find out more about the winners of our Innovation Prize in Boston, New York and San Diego in the USA; Tokyo Japan and Vienna, Austria

Regional experts highlight need for coordinated, collaborative efforts in stroke care through

Regional experts highlight need for coordinated, collaborative efforts in stroke care through dedicated hospital unitsRegional experts highlight need for coordinated, collaborative efforts in stroke care through dedicated hospital units

COVID-19 General Q&A

10 tips cat friendly veterinary clinics

Here are 10 simple steps you can take to make feline patients feel at ease at your practice.

Oncology and Cancer Immunology Research

Find out more about our research and development in oncology and cancer immunology.

History of the logo

Overview of the history of the corporate logo of Boehringer Ingelheim, from the founding years of the company until today

Scleroderma Life Hacks

Video series featuring people living with scleroderma using everyday items in different ways to help them manage their symptoms. Part of the global 'More Than Scleroderma' initiative developed by Boehringer Ingelheim, with support from patient organi

Different life stages dogs preventive health

What does your dog need to thrive at every age? Get some tips here!

Fabio Paganini fostering inclusion & agility in AH

How employees are contributing to an inclusive culture at Boehringer Ingelheim.

Contact us

Find all our contact information here about our BD&L team.

Advice to Fellow Patients

People living with cancer share their advice for fellow patients, from checking information sources to living in the present moment.

Angels Initiative in South Africa

Dr Stacey Rossouw explains how the Angels initiative is making a difference in South Africa and optimizing stroke care

About Us

Human Health

Animal Health

Science & Innovation

Partnering